Literature DB >> 961766

In vitro perfusion of human placenta. V. Oxygen consumption.

J C Challier, H Schneider, J Dancis.   

Abstract

02 consumption by human term placenta has been measured during perfusion in vitro, with a technique that permits perfusion of the intervillous space as well as the umbilical circulation. The rate at which 02 was consumed was directly related to the rate at which it was supplied, within the limits studied. Previous estimates of 02 consumption yielded figures approximating 3 ml. per minute per kilogram of placenta, but these estimates were attained under conditions of limited oxygen supply. When oxygen was delivered to the placenta at rates believed to be those achieved in vivo, oxygen consumption approximated 10 ml. per minute per kilogram. This rate of 02 consumption is similar to those obtained from studies of animal placentas in vivo and is more consistent with that of an active metabolic organ. If one were to accept estimates of 02 consumption by the human fetus in utero, the present studies indicate that approximately one fifth of maternal oxygen supplied to the conceptus is diverted to support placental metabolism.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 961766     DOI: 10.1016/0002-9378(76)90287-8

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  3 in total

1.  Placental transfer of theophylline in an in vitro closed perfusion system of human placenta isolated lobule.

Authors:  D Omarini; M M Barzago; A Bortolotti; G Lucchini; F Stellari; S Efrati; M Bonati
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1993 Oct-Dec       Impact factor: 2.441

2.  Calcium transport across the isolated dually perfused human placental lobule.

Authors:  D R Abramovich; C G Dacke; C Elcock; K R Page
Journal:  J Physiol       Date:  1987-01       Impact factor: 5.182

3.  Metabolism of dehydroepiandrosterone (DHA) in the mature perfused human placenta (I).

Authors:  A S Wolf; K Musch; D Breitig; C Lauritzen
Journal:  J Endocrinol Invest       Date:  1982 May-Jun       Impact factor: 4.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.